E-LIB Suche - Ergebnisse für: Rametta, Mark

1

A Prospective, Observational, Multicenter Study Assessing A..:

Farej, Ryan ; Rametta, Mark ; La Rose, Anneliese..
Neurology and Therapy. 11 (2022) 1 - p. 373-384 , 2022

Link: https://doi.org/10.1007/..

2

Real-World Assessment of Interferon-β-1b and Interferon-β-1..:

Butler, Oisín ; Heeg, Simone ; Holl, Katsiaryna...
Drugs - Real World Outcomes. 8 (2021) 3 - p. 359-367 , 2021

Link: https://doi.org/10.1007/..

3

Sentiment of Media Coverage and Reputation of the Pharmaceu..:

Pampulevski, Valentina ; Giaquinto, Jessica R. ; Rametta, Mark...
Therapeutic Innovation & Regulatory Science. 54 (2020) 1 - p. 220-225 , 2020

Link: https://doi.org/10.1007/..

4

Sentiment of Media Coverage and Reputation of the Pharmaceu..:

Pampulevski, Valentina ; Giaquinto, Jessica R. ; Rametta, Mark...
Therapeutic Innovation & Regulatory Science. , 2019

Link: https://doi.org/10.1177/..

5

Exploring the Role of the Microbiome in Multiple Sclerosis:

US Medical Affairs, Neurology, Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ, USA ; Ashton MediCom, Salfords, Surrey, UK ; Clinical Nutrition–Private Practice, Sparta, NJ, USA...
US Neurology. 15 (2019) 2 - p. 82 , 2019

Link: https://doi.org/10.17925..

6

Short-term and long-term safety and tolerability of interfe..:

Reder, Anthony T. ; Oger, Joel F. ; Kappos, Ludwig..
Multiple Sclerosis and Related Disorders. 3 (2014) 3 - p. 294-302 , 2014

Link: https://doi.org/10.1016/..

7

Causes of Death among Commercially Insured Multiple Scleros..:

Goodin, Douglas S. ; Corwin, Michael ; Kaufman, David...
PLoS ONE. 9 (2014) 8 - p. e105207 , 2014

Link: https://doi.org/10.1371/..

8

Immune response during interferon beta-1b treatment in pati..:

Dhib-Jalbut, Suhayl ; Sumandeep, Sumandeep ; Valenzuela, Reuben...
Journal of Neuroimmunology. 254 (2013) 1-2 - p. 131-140 , 2013

Link: https://doi.org/10.1016/..

9

Cause of death in MS: long-term follow-up of a randomised c..:

Goodin, Douglas S ; Ebers, George C ; Cutter, Gary...
BMJ Open. 2 (2012) 6 - p. e001972 , 2012

Link: https://doi.org/10.1136/..

10

A Prospective, Observational, Multicenter Study Assessing A..:

Farej, Ryan ; Rametta, Mark ; La Rose, Anneliese..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857376/. , 2022

Link: http://www.ncbi.nlm.nih...

11

Real-World Assessment of Interferon-β-1b and Interferon-β-1..:

Butler, Oisín ; Heeg, Simone ; Holl, Katsiaryna...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324614/. , 2021

Link: http://www.ncbi.nlm.nih...

12

Survey of US Patients with Multiple Sclerosis: Comparison o..:

Barone, Donald A ; Singer, Barry A ; Merkov, Lubo..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130914/. , 2016

Link: http://www.ncbi.nlm.nih...

13

Patient Satisfaction with the New Interferon Beta-1b Autoin..:

Ziemssen, Tjalf ; Sylvester, Lauren ; Rametta, Mark.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685867/. , 2015

Link: http://www.ncbi.nlm.nih...

14

Cause of death in MS: long-term follow-up of a randomised c..:

Goodin, Douglas S ; Ebers, George C ; Cutter, Gary...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533062. , 2012

Link: http://www.ncbi.nlm.nih...

15

The Combined Effect of Nursing Support and Adverse Event Mi..:

Dhib-Jalbut, Suhayl ; Markowitz, Clyde ; Patel, Payal..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3882987. , 2012

Link: http://www.ncbi.nlm.nih...